Home Diagnostics Market | Abbott Laboratories, ACON Laboratories Inc., BTNX Inc., ARKRAY Inc., Assure Tech (Hangzhou) co. Ltd., Becton Dickinson & Company, Bionime Corporation, Roche Holding AG, Quidel Corporation, and True Diagnostics Inc.

Key Insights

Market Players Adopt Next-generation Technologies to Improve Existing Home Diagnostic Test Kits

Rising health awareness has driven adoption of personalized medicines and home diagnostics among consumers. Sensing the requirements of end-users, home diagnostics market players are focusing on enhancing efficiency, accuracy, reliability, and convenience. The investments have invariably shifted to incorporation of advanced technology in the manufacture of home diagnostics. Through adoption of wearable technologies, Internet of Things (IoT), and Artificial Intelligence (AI), market players are working on enhancing the performance features of home diagnostics. For instance, Siemens Healthcare and Abbott Technologies, are introducing various types of digital home diagnostics that can be integrated with smartphones, which may become an emerging market trend in the upcoming years.

Request Sample Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=1892 

Low Penetration of Home Diagnostics in Emerging Markets: A Longstanding Challenge

Developed countries are witnessing rising adoption of advanced technologies to develop highly-efficient home diagnostics with the increasing focus on R&D Consumers are becoming more aware of the availability of home diagnostics that can enable them to conduct in vitro diagnosis tests at home without the need for any professional assistance. However, lower health awareness in developing nations, especially in Asia and the Middle East & Africa, is restricting the adoption of home diagnostics. Despite the larger consumer base and growing number of deaths caused due to chronic diseases, penetration of home diagnostics remains low in emerging markets. Leading manufacturers in the home diagnostics market are home diagnostics market are modifying their marketing strategies to scale up their presence in developing nations and boost regional economic growth in the upcoming years.

Home Diagnostics Continues to be a Heavily Regulated Industry

As home diagnostics help patients to detect diseases without any professional medical assistance, the accuracy and precision of the results provided by these tests plays an important role in the performance of home diagnostics. Taking into consideration the pervasiveness of home diagnostics, governing organizations across the world are imposing stringent rules and regulations to ensure the quality and reliability of home diagnostics marketed worldwide. Home diagnostics manufacturers need to comply with Section 510(k) of the Food, Drug and Cosmetic Act and get Premarket Approval Application (PMA) approvals established by FDA to enter the US home diagnostics market. In addition, the European Union has imposed regulations, such as Medical Devices Regulation 2017/745/EU and In Vitro Diagnostic Medical Devices Regulation 2017/746/EU that all the stakeholders in the home diagnostics market need to comply with. Strict quality control regulations and labeling requirements may influence growth prospects of the home diagnostics market, as they may make it difficult for market players to reduce manufacturing costs.

Browse Full Report @ https://www.factmr.com/report/1892/home-diagnostics-market 

Rising Incidences of Diabetes and Other Lifestyle Diseases Fueling Demand for Home Diagnostic Solutions

The number of patients suffering from diabetes across the world has increased from 108 million in 1980 to around 422 million in 2014, which the World Health Organization (WHO) predicts to become a leading cause of death by 2030. Anticipating the rapidly increasing prevalence of diabetes, leading manufacturers in the home diagnostics market are adopting strategies to provide glucose monitoring devices, which may witness higher demand in the coming future. Further, the number of Americans suffering from hearing loss has doubled in last fifteen years, which is encouraging stakeholders in the home diagnostics market to introduce hearing assessment kits. Keeping a close look at dynamic prevalence of various health conditions is helping home diagnostics manufacturers to discover useful insights, which are enabling them to plan appropriate business strategies in the near future.

Initiatives by International Organizations to Promote Health Awareness Likely to Boost Adoption of Home Diagnostics

Alarming rise in the number of incidences of lifestyle diseases and deaths causes due to chronic health disorders is influencing health organizations and governing bodies to shift their focus on improving the quality of diagnostic services. As stated by the WHO that “an accurate diagnosis is the first step to getting effective treatment,” awareness about the importance of home diagnostics is increasing among governing bodies. The WHO recently released the Essential Diagnostics List, which recognizes home diagnostics as a vital element to improve global health coverage. As enhancing the quality of diagnosis is one of the priorities of the WHO Thirteenth General Programme of Work (2019–2023) (GPW), the initiates taken by the organization may help stakeholders in the home diagnostics market to boost ales in the upcoming years.

Speak To Research Analyst for Detailed Insights @ https://www.factmr.com/connectus/sample?flag=AE&rep_id=1892 

Competitive Analysis

The Fact.MR report helps readers to track the salient developments in strategies adopted by their competitors in the home diagnostics market and plan their upcoming strategies accordingly. The report covers all the leading stakeholders in the home diagnostics market and provides detailed information including the company revenues as well as their business plans for the coming future. Market players in the home diagnostics market that are featured in the report include Abbott Laboratories, ACON Laboratories Inc., BTNX Inc., ARKRAY Inc., Assure Tech (Hangzhou) co. Ltd., Becton Dickinson & Company, Bionime Corporation, Roche Holding AG, Quidel Corporation, and True Diagnostics Inc.

Leading market players in the home diagnostics market are adopting collaborative strategies to scale up their presence in the highly competitive environment in the global diagnostics industry. For example, in order to expand its innovative diagnostics portfolio, Quidel Corportation recently acquired Alere Triage® assets including its cardiovascular & toxicology business and B-type Naturietic Peptide (BNP) assay business. Another leading stakeholder in the home diagnostics market – Roche Holding AG entered into a strategic partnership with GE Healthcare to deliver in-vivo and in-vitro data-driven diagnostics, which include tests that critical care patients can use at home.

Japan’s largest diagnostics company – ARKRAY, Inc. recently entered an agreement to acquire in-vitro diagnostics unit of Span Divergent Ltd. – a leading manufacturer of home diagnostics in the Indian healthcare sector. Furthermore, leading market players, including Abbott Laboratories, True Diagnostics Inc., and ACON Laboratories, are incorporating innovative technologies to further improve performance features, such as efficiency and accuracy, to gain a competitive edge in the home diagnostics market.

Definition

Home diagnostics, also known as in vitro diagnostics or self-diagnosis tests, are tests performed on samples collected from the human body, which include blood, urine, and saliva, to detect medical conditions or diseases at home. Home diagnostics are popular among patients as these tests are quick, cost-effective, and confidential. Home diagnostics are commonly available in the form of cassettes, strips, digital monitoring instruments, cups, and dip cards.

About the Report

The Fact.MR report includes detailed information about the home diagnostics market on thoroughly assessing historical and the latest industry-validated data associated with home diagnostics. Readers can find accurate information about the future prospects of the home diagnostics market, which can help market players to comprehend the ebb and flow of the home diagnostics market during the period 2018-2026.

Segmentation

The report includes detailed segmentation of the home diagnostics market according to regional markets, test types, form types, distribution channels, and sample channels, to help readers to understand growth prospects of the home diagnostics market with more clarity. Based on regional markets for home diagnostics, the market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East & Africa, and China. The home diagnostics market is divided into six main categories according to various test types, such as glucose monitoring devices, pregnancy tests, HIV test kits, ovulation prediction test kits, cholesterol test kits, and drug abuse test kits, which is further segmented into marijuana kits, opiates kits, benzodiazepines, and alcohol abuse kits. Other test types included in the home diagnostics market report are male infertility test kits, urinary tract infections test, menopause test kits, and fecal occult blood test. The home diagnostics market is further segmented into various form types, such as cassette, strip, midstream, digital monitoring instrument, test panel, cup, and dip card. Based on distribution channels, the home diagnostics market is segmented into retail pharmacies, drug store, supermarket/hypermarket, and online pharmacies. The home diagnostics market is also segmented according to sample types into blood, saliva, and urine.

Additional Questions Answered

The report provides information about all-encompassing factors that are making a significant impact on the growth of the home diagnostics market. Furthermore, readers can also find answers to their special questions associated with various other aspects of the development of the home diagnostics market, in the report. Some of those questions include

Which types of home diagnostic test types are most of the leading market players concentrating on producing?
What are the risks on investing in home diagnostics markets in developing countries?
What the most important factors that are triggering adoption of glucose monitoring devices worldwide?
How will growing adoption of digital monitoring instruments impact growth prospects of the home diagnostics market in the near future?
Which distribution channel can help market players to improve the home diagnostic sales in developing countries?
Research Methodology

Fact.MR study provides thorough information about the growth prospects of the home diagnostics market by conducting a thorough research on the development of the home diagnostics market over the past few years. Analysts at Fact.MR conduct a comprehensive secondary research to understand the historical as well as current industry data about the expansion of home diagnostics market. Further, through an extensive primary research, where analysts interview leading market players in the home diagnostics market to gather authentic values that define their growth, to verify the information obtained through secondary research. The research methodology followed at Fact.MR to analyze the growth parameters of the home diagnostics market confirms the authenticity of the information to provide accurate information about the market to readers.

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: www.factmr.com/

Read Industrial News : https://theswisstimes.com/

This release was published on openPR.